Clinical Significance: Secobarbital is a barbituate used in the treatment of epilepsy and insomnia.
Tested in urine only

Drug Class

Barbituates

Metabolite(s)

None

Aliases

Seconal

Methodology

Enzyme Immunoassay/Liquid Chromatography Mass Spectrometry

Urine Recommended Volume

30mL

Oral Fluid Minimum Volume

N/A

Specimen Stability

15 days

Urine Reportable Range

200-2000

Oral Fluid Reportable Range

N/A

Urine Immunoassay Cutoff (ng/mL)

200

Urine Window of Detection

2-7 days

Oral Fluid Window of Detection

N/A

Rejection Criteria

Quantity Not Sufficient

Urine Transient Contanier

Urine Clinical Drug Test Transport Cup

Oral Fluid Transient Contanier

N/A